Skip to main content

Cefdinir Pregnancy and Breastfeeding Warnings

Brand names: Omnicef, Omnicef Omni-Pac

Medically reviewed by Drugs.com. Last updated on Aug 4, 2023.

Cefdinir Pregnancy Warnings

Cefdinir has been assigned to pregnancy category B by the FDA. Animal studies have revealed evidence of maternal toxicity (decreased body weight gain) and decreased fetal body weight. There are no controlled data in human pregnancy. Cefdinir should be given during pregnancy only if need is clearly established.

See references

Cefdinir Breastfeeding Warnings

Following administration of single 600 mg doses, cefdinir has not been detected in human breast milk. Other cephalosporins have been classified as compatible with breast-feeding by the American Academy of Pediatrics.

See references

See also

References for pregnancy information

  1. (2001) "Product Information. Omnicef (cefdinir)." Parke-Davis

References for breastfeeding information

  1. (2001) "Product Information. Omnicef (cefdinir)." Parke-Davis
  2. Briggs GG, Freeman RK, Yaffe SJ.. (1998) "Drugs in Pregnancy and Lactation." Baltimore, MD: Williams & Wilkins

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer